Crinetics Pharmaceuticals (CRNX) Long-Term Deferred Tax (2023 - 2024)

Crinetics Pharmaceuticals' Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $291.5 million for Q4 2024.

• In Q4 2024, Long-Term Deferred Tax changed N/A year-over-year to $291.5 million; the TTM figure through Dec 2024 stood at $291.5 million (changed N/A YoY), while the FY2024 annual figure was $291.5 million, changed N/A from the prior year.
• Long-Term Deferred Tax for Q4 2024 stood at $291.5 million.
• The five-year high for Long-Term Deferred Tax was $291.5 million in Q4 2024, with the low at $291.5 million in Q4 2024.